Founder-backed investment supports accelerated clinical development through a fully funded Phase 1/2 program GREENWICH, Conn., Aug. 3, 2026 /PRNewswire/ -- Ceruvia Lifesciences, a leading ...

Detailed price information for Betterlife Pharma Inc (BETRF) from The Globe and Mail including charting and trades.

Psychedelic drug development has increasingly focused on separating potential therapeutic effects from the hallucinogenic experience. One emerging approach preserves the molecular foundation of ...

Vancouver, British Columbia--(Newsfile Corp. - June 25, 2026) - BetterLife Pharma Inc. (CSE: BETR) (OTCQB: BETRF) (FSE: NPAU) ("BetterLife" or the "Company ...

Who knew hallucinogens were actually good for you? In a recent study, two psychiatrists discovered that patients suffering from agonizing cluster headaches found relief while taking LSD or other ...

BetterLife intends to deploy net proceeds to conduct Phase 1A studies in healthy volunteers, run Phase 1B clinical trials for cluster headache and migraine concurrently rather than sequentially, and ...

Add Yahoo as a preferred source to see more of our stories on Google. A single dose of the psychedelic drug LSD may ease generalized anxiety disorder for months, a clinical trial has found. The trial ...

Clinical development veteran to lead execution of the first-in-human study of BETR-001 ahead of programs in chronic cluster headache and chronic migraineVancouver, British Columbia--(Newsfile Corp. - ...

As psychedelic drugs such as LSD gain new momentum as treatments for severe post-traumatic stress disorder (PTSD), depression and even headaches, a University at Buffalo researcher is exploring safety ...

Move over Xanax, Prozac, and Duloxetine? A recent study comparing a single oral dose of MM120 (LSD) with a placebo suggests that LSD may be an effective treatment for anxiety. More recently, Definium ...